Literature DB >> 3146583

Use of heat inactivated viral haemorrhagic fever antigens in serological assays.

J F Saluzzo1, B Leguenno, G Van der Groen.   

Abstract

Heating for 1 h at 60 degrees C completely destroyed the infectivity of sucrose-acetone-extracted antigen of Rift Valley (RVF) and Congo Crimean haemorrhagic fever (CCHF), as well as of RVF- and CCHF-infected mouse brain. These antigens could be successfully used, however, for complement fixation and IgM-capturing enzyme immunoassay. Vero E6 cell suspensions infected with hantaviruses such as Hantaan 76-118, Tchoupitoulas, SR 11, GB-B, CG 18-20, Hällnäs, CG 13891, Seoul and Prospect Hill, as well as Vero cells infected with CCHF and RVF viruses, were completely inactivated after heating for 1 h at 60 degrees C. Indirect immunofluorescent antibody test results obtained on slides prepared with heat-inactivated cell suspensions correlated well with results obtained on slides prepared with unheated cell suspensions. Inactivation is a simple, rapid, economic and reproducible method for inactivation of hantaviruses and CCHF and RVF viruses, with preservation of the ability to react specifically with antibodies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3146583     DOI: 10.1016/0166-0934(88)90099-7

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  4 in total

1.  A novel mu-capture enzyme-linked immunosorbent assay based on recombinant proteins for sensitive and specific diagnosis of hemorrhagic fever with renal syndrome.

Authors:  L G Zöller; S Yang; P Gött; E K Bautz; G Darai
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

2.  Effective chemical virus inactivation of patient serum compatible with accurate serodiagnosis of infections.

Authors:  M M Remy; M Alfter; M-N Chiem; M T Barbani; O B Engler; F Suter-Riniker
Journal:  Clin Microbiol Infect       Date:  2018-10-28       Impact factor: 8.067

3.  Effective inactivation of Nipah virus in serum samples for safe processing in low-containment laboratories.

Authors:  Shumpei Watanabe; Shuetsu Fukushi; Toshihiko Harada; Masayuki Shimojima; Tomoki Yoshikawa; Takeshi Kurosu; Yoshihiro Kaku; Shigeru Morikawa; Masayuki Saijo
Journal:  Virol J       Date:  2020-10-09       Impact factor: 4.099

4.  Heat inactivation of the severe acute respiratory syndrome coronavirus 2.

Authors:  Christophe Batéjat; Quentin Grassin; Jean-Claude Manuguerra; India Leclercq
Journal:  J Biosaf Biosecur       Date:  2021-01-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.